PatientsVille.com Logo

PatientsVille

Oscal Side Effects

Common Oscal Side Effects


The most commonly reported Oscal side effects (click to view or check a box to report):

Feeling Hot (4)
Fall (4)
Arthralgia (3)
Fatigue (2)
Dyspnoea (2)
Chills (2)
Cough (2)
Diarrhoea (2)
Flushing (2)
Pulmonary Embolism (2)
Haemorrhage (2)
Nausea (2)
Sinusitis (2)
Myalgia (2)
Hypertension (2)
Nasopharyngitis (1)
Myocardial Infarction (1)
No Therapeutic Response (1)
Oedema Peripheral (1)
No Adverse Event (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Oscal Side Effects Reported to FDA

The following Oscal reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Oscal on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Infusion Site Pain, Musculoskeletal Pain
This is a report of a 51-year-old female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Oscal (calcium Carbonate) (dosage: NA, start time: NS), combined with:
  • Reclast (5 Mg. , Infusion)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Infusion Site Pain
  • Musculoskeletal Pain
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Oscal (calcium Carbonate) treatment in female patients, resulting in infusion site pain side effect.


This report suggests a potential Oscal 500 + D side effect(s) that can have serious consequences. A 64-year-old female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: NA and used Oscal 500 + D (dosage: NA) starting NS. Soon after starting Oscal 500 + D the patient began experiencing various side effects, including:
    Drugs used concurrently:
    • Prochlorperazine
    • Tykerb (750mg Per Day)
    • Multi-vitamin
    • Tylenol (caplet)
    Although Oscal 500 + D demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as death, may still occur.

    Fall, Thrombosis, Spinal Pain, Spinal Fracture
    This Fall, Thrombosis, Spinal Pain, Spinal Fracture problem was reported by a consumer or non-health professional from BRAZIL. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: bone disorder,hypertension. On NS this consumer started treatment with Oscal D (dosage: 1 Df, Daily). The following drugs were being taken at the same time:
    • Diovan Hct (1 Df, Daily (160/12.5 Mg))
    When commencing Oscal D, the patient experienced the following unwanted symptoms/side effects:
    • Fall
    • Thrombosis
    • Spinal Pain
    • Spinal Fracture
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as fall, may become evident only after a product is in use by the general population.

    Pulmonary Embolism, Abdominal Pain, Myalgia, Arthralgia, Diarrhoea, Nausea, Chest Pain, Bone Pain
    This is a report of a 42-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Oscal (calcium Carbonate) (dosage: NA) starting May 10, 2009. Concurrently used drugs:
    • Topamax
    • Gleevec (400 Mg, Qd, Oral)
    • Estrace
    • Vitamin Tab
    • Allopurinol
    • Ibuprofen (advil)
    • Prilosec
    • Welchol
    Soon after that, the consumer experienced the following side effects:
    • Pulmonary Embolism
    • Abdominal Pain
    • Myalgia
    • Arthralgia
    • Diarrhoea
    • Nausea
    • Chest Pain
    • Bone Pain
    The patient was hospitalized. This opens a possibility that Oscal (calcium Carbonate) treatment could cause the above reactions, including pulmonary embolism, and some female subjects may be more susceptible.


    Haemorrhage
    A 94-year-old female patient (weight: NA) from UNITED STATES with the following symptoms/conditions: NA started Oscal (calcium Carbonate) treatment (dosage: NA) on NS. Soon after starting Oscal (calcium Carbonate) treatment, the subject experienced various side effects, including:
    • Haemorrhage
    Concurrently used drugs:
    • Acetaminophen
    • Lisinopril
    • Furosemide
    • Vitamin D
    • Omeprazole
    • Eylea (Intravitreal)
    • Crestor
    • Ascorbic Acid
    The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Oscal (calcium Carbonate).

    White Blood Cell Count Decreased, Myalgia, Haemoglobin Decreased, Thrombocytopenia, Hepatic Enzyme Abnormal, Headache, Dyspnoea, Fluid Retention, Abdominal Distension
    A 89-year-old male patient from UNITED STATES (weight: NA) experienced symptoms, such as: NA and was treated with Oscal (calcium Carbonate)(dosage: NA). The treatment was initiated on Apr 28, 2009. After that a consumer reported the following side effect(s):
    • White Blood Cell Count Decreased
    • Myalgia
    • Haemoglobin Decreased
    • Thrombocytopenia
    • Hepatic Enzyme Abnormal
    • Headache
    • Dyspnoea
    • Fluid Retention
    • Abdominal Distension
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Oscal (calcium Carbonate) efficacy:
    • Lyrica
    • Gleevec (400 Mg, Bid, Oral, 200 Mg, Qd)
    • Gleevec (400 Mg, Bid, Oral, 200 Mg, Qd)
    • Sinemet


    Hypocalcaemia
    In this report, Oscal D was administered for the following condition: NA.A male consumer from UNITED STATES (weight: NA) started Oscal D treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Hypocalcaemia
    A possible interaction with other drugs could have contributed to this reaction:
    • Vitamin B-12 (Unk)
    • Toprol-xl (Unk)
    • Coumadin (Unk)
    • Prolia (Unk Unk, Q6mo)
    • Digoxin (Unk)
    • Androgel (Unk)
    • Omeprazole (Unk)
    Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Oscal D treatment could be related to the listed above side effect(s).

    Blood Calcium Decreased, Pigmentation Disorder, Back Pain, Blood Potassium Increased, Arthralgia, Skin Exfoliation, Muscle Spasms, Diarrhoea, Fatigue
    This is a report of the following Oscal D side effect(s):
    • Blood Calcium Decreased
    • Pigmentation Disorder
    • Back Pain
    • Blood Potassium Increased
    • Arthralgia
    • Skin Exfoliation
    • Muscle Spasms
    • Diarrhoea
    • Fatigue
    A 65-year-old female patient from UNITED STATES (weight: NA) presented with the following condition: NA and received a treatment with Oscal D (dosage: Unk) starting: Dec 15, 2011.The following concurrently used drugs could have generated interactions:
    • Prevacid
    • Multi-vitamin
    • Prolia (60 Mg, Q6mo)
    • Keralyt (Unk)
    • Ranitidine (Unk)
    • Azathioprine (Unk)
    • Cetirizine (Unk)
    • Magnesium (Unk)
    This report suggests that a Oscal D treatment could be associated with the listed above side effect(s).

    Feeling Hot, Dry Mouth
    This Oscal (calcium Carbonate) (calcium Carbonate) report was submitted by a female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: NA and Oscal (calcium Carbonate) (calcium Carbonate) was administered (dosage: NA) starting: Oct 28, 2011. The consumer developed a set of symptoms:
    • Feeling Hot
    • Dry Mouth
    Other drugs used simultaneously:
    • Gabapentin
    • Benlysta (1 In 28 D, Intravenous Drip)
    • Hydroxychloroquine (hydroxychloroquine) (hydroxychloroquine)
    • Nabumetone (nabumetone) (nabumetone)
    • Omega-3-acid Ethyl Esters (lovaza)
    Those unexpected symptoms could be linked to a Oscal (calcium Carbonate) (calcium Carbonate) treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Device Malfunction, Injury, Fall, Clavicle Fracture, Pelvic Fracture
    This is a report of a possible correlation between Oscal D use and the following symptoms/side effect(s):
    • Device Malfunction
    • Injury
    • Fall
    • Clavicle Fracture
    • Pelvic Fracture
    which could contribute to an assessment of Oscal D risk profile.A female consumer from UNITED STATES (weight: NA) was suffering from NA and was treated with Oscal D (dosage: NA) starting Jan 01, 2011.Other concurrent medications:
    • Humira
    • Multi-vitamins
    The patient was hospitalized.

    Iron Deficiency Anaemia
    A 80-year-old female patient from UNITED STATES (weight: NA) presented with the following symptoms: mineral supplementation and after a treatment with Oscal (dosage: 600 Mg, Qd) experienced the following side effect(s):
    • Iron Deficiency Anaemia
    The treatment was started on May 28, 2011. Oscal was used in combination with the following drugs:
    • Synthroid (25 Mg, Qd)
    • Recombinant Protein Of Human Vegf Receptors (vegfr1+vegfr2) (13 Doses Of Vgft 0.5 Mg Or 2.0 Mg Or Ranibizumab 0.5 Mg (q4wks) In Year 1 Of Vgft-od-0605)
    • Recombinant Protein Of Human Vegf Receptors (vegfr1+vegfr2) (5 Doses Of Vgft 0.5 Mg Or 2.0 Mg Or Ranibizumab 0.5 Mg (q4wks/q12wks/prn) In Year 2 Of Vgft-od-0605)
    • Recombinant Protein Of Human Vegf Receptors (vegfr1+vegfr2) (2 Mg, Prn)
    • Centrum Silver (1 Df, Qd)
    • Vitamin D (1 Df, Qd)
    • Cyclobenzaprine
    • Advair Diskus 100/50
    The patient was hospitalized.This report could alert potential Oscal consumers.

    No Adverse Event
    In this report, a 75-year-old female patient from UNITED STATES (weight: NA) was affected by a possible Oscal side effect.The patient was diagnosed with NA. After a treatment with Oscal (dosage: NA, start date: Nov 17, 2008), the patient experienced the following side effect(s):
    • No Adverse Event
    The following simultaneously used drugs could have led to this reaction:
    • Aspirin
    • Vitamin B6
    • Lorazepam
    • Triamterene
    • Xeloda (Dosage:14days On/7days Off)
    • Ciprofloxacin
    • Multi-vitamins (1 Df= 8 Unit Nos)
    • Zometa (1 Df:3.3 To 3.5mg)
    The findings here stress that side effects should be taken into consideration when evaluating a Oscal treatment.

    Haematochezia, Nausea
    This is a report of a 75-year-old female patient from UNITED STATES (weight: NA), who used Oscal-d (dosage: NA) for a treatment of NA. After starting a treatment on Nov 11, 2011, the patient experienced the following side effect(s):
    • Haematochezia
    • Nausea
    The following drugs could possibly have interacted with the Oscal-d treatment
    • Mucinex
    • Centrum
    Taken together, these observations suggest that a Oscal-d treatment could be related to side effect(s), such as Haematochezia, Nausea.

    Injection Site Erythema, Injection Site Pain, Injection Site Swelling
    This injection site erythema side effect was reported by a consumer or non-health professional from UNITED STATES. A 59-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Oscal /00108001/ (dosage: NA), which was started on NS. Concurrently used drugs:
    • Enbrel (50 Mg, Qwk)
    • Vitamin B Complex Cap
    • Sectral (200 Mg, Unk)
    • Multivitamin /00097801/
    When starting to take Oscal /00108001/ the consumer reported the following symptoms:
    • Injection Site Erythema
    • Injection Site Pain
    • Injection Site Swelling
    These side effects may potentially be related to Oscal /00108001/.

    Foot Fracture, Coronary Artery Stenosis, Arthritis, Cataract Operation, Delirium Tremens, Gastric Polyps, Acute Prerenal Failure, Heart Transplant Rejection, Cough
    This is a Oscal side effect report of a male patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Oscal (dosage:Unk, start time: Feb 11, 1993), combined with:
    • Prograf (0.5 Mg, Bid)
    • Aspirin (Unk)
    • Losartan Potassium (Unk)
    • Prograf (3 Mg, Bid)
    • Diltiazem Hcl (90 Mg, Bid)
    • Enalapril Maleate (5 Mg, Uid/qd)
    • Pravastatin (10 Mg, Uid/qd)
    • Prograf (2 Mg, Bid)
    , and developed a serious reaction and a foot fracture side effect. The patient presented with:
    • Foot Fracture
    • Coronary Artery Stenosis
    • Arthritis
    • Cataract Operation
    • Delirium Tremens
    • Gastric Polyps
    • Acute Prerenal Failure
    • Heart Transplant Rejection
    • Cough
    which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Oscal treatment in male patients suffering from NA, resulting in foot fracture.

    Joint Crepitation, Artificial Crown Procedure
    This report suggests a potential Oscal D /06435501/ joint crepitation side effect(s) that can have serious consequences. A 77-year-old female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): NA and used Oscal D /06435501/ (dosage: 1 Unk, Unk) starting Mar 01, 2011. Soon after starting Oscal D /06435501/ the patient began experiencing various side effects, including:
    • Joint Crepitation
    • Artificial Crown Procedure
    Drugs used concurrently:
    • Hydrochlorothiazide (Unk Unk, Qd)
    • Venlafaxine Hydrochloride (1 Unk, Unk)
    • Prolia (60 Mg, Q6mo)
    • Centrum Silver /01292501/
    • B12 /00056201/
    • Omeprazole (1 Unk, Unk)
    • Motrin (Unk Unk, Prn)
    • Osteo Bi-flex (1 Unk, Unk)
    Although Oscal D /06435501/ demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as joint crepitation, may still occur.

    Feeling Hot, Flushing, Burning Sensation
    This feeling hot problem was reported by a consumer or non-health professional from UNITED STATES. A female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Jan 01, 2007 a consumer started treatment with Oscal 500+d (dosage: NA). The following drugs/medications were being taken at the same time:
    • Niaspan (At Bedtime)
    • Vytorin
    • Niaspan
    When commencing Oscal 500+d, the patient experienced the following unwanted symptoms /side effects:
    • Feeling Hot
    • Flushing
    • Burning Sensation
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as feeling hot, may become evident only after a product is in use by the general population.

    Oedema Peripheral, Speech Disorder, Vitamin D Deficiency, Swelling Face, Dyspnoea
    This is a Oscal 500-d side effect report of a female patient (weight: NA) from BRAZIL. The patient developed the following symptoms/conditions: NA and was treated with Oscal 500-d (dosage: NA) starting Aug 19, 2010. Concurrently used drugs:
    • Levothyroxine Sodium (100 Ug, Unk)
    • Metoprolol Succinate (50 Mg, Unk)
    • Somalgin (100 Mg, Unk)
    • Exforge (1 Df(160/ 5 Mg), Unk)
    • Emama (400 Mg, Unk)
    Soon after that, the consumer experienced the following of symptoms:
    • Oedema Peripheral
    • Speech Disorder
    • Vitamin D Deficiency
    • Swelling Face
    • Dyspnoea
    This opens a possibility that Oscal 500-d could cause oedema peripheral and that some female patients may be more susceptible.

    Anxiety, Blood Pressure Inadequately Controlled, Cerebrovascular Accident, Hemiplegia, Diabetes Mellitus, Osteopenia
    A 62-year-old female patient (weight: NA) from BRAZIL with the following symptoms: osteopenia,hypertension,hypercholesterolaemia started Oscal treatment (dosage: NA) on Oct 01, 2010. Soon after starting Oscal treatment, the consumer experienced several side effects, including:
    • Anxiety
    • Blood Pressure Inadequately Controlled
    • Cerebrovascular Accident
    • Hemiplegia
    • Diabetes Mellitus
    • Osteopenia
    . Concurrently used drugs:
    • Metoprolol Succinate
    • Vytorin (Od)
    • Atacand
    The patient was hospitalized and became disabled. This finding indicates that some patients can be more vulnerable to developing Oscal side effects, such as anxiety.

    Epistaxis, Sinusitis, Renal Colic, Procedural Pain, Blood Cholesterol Increased, Hypertension, Skin Discolouration, Pain In Extremity, Feeling Hot
    This epistaxis side effect was reported by a consumer or non-health professional from BRAZIL. A female patient (weight:NA) experienced the following symptoms/conditions: osteopenia.The patient was prescribed Oscal (dosage: 500 Mg, Unk), which was started on Oct 01, 2010. Concurrently used drugs:
    • Deflazacort (6 Mg, Unk)
    • Tofranil (25 Mg, Unk)
    • Tocilizumab (8 Mg/kg, Unk)
    • Methotrexate (15 Mg, Unk)
    • Clonazepam (.2 Mg, Unk)
    • Rituximab (1000 Mg, Unk)
    • Cymbalta (60 Mg, Unk)
    • Meloxicam (7.5 Mg, Unk)
    .When starting to take Oscal the consumer reported symptoms, such as:
    • Epistaxis
    • Sinusitis
    • Renal Colic
    • Procedural Pain
    • Blood Cholesterol Increased
    • Hypertension
    • Skin Discolouration
    • Pain In Extremity
    • Feeling Hot
    These side effects may potentially be related to Oscal.

    Leukopenia, Granulocytopenia
    This is a report of a 41-year-old female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Oscal /00108001/ (dosage: NA, start time: Apr 30, 2010), combined with:
    • Clozapine
    • Depakote Er
    • Clozapine
    • Multi-vitamin
    • Clozapine
    • Cymbalta
    • Clozapine
    and developed a serious reaction and side effect(s). The consumer presented with:
    • Leukopenia
    • Granulocytopenia
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Oscal /00108001/ treatment in female patients, resulting in leukopenia side effect.

    Respiratory Tract Congestion, Sinusitis, Hyperhidrosis, Tubulointerstitial Nephritis, Dehydration, Micturition Urgency, Renal Failure Acute, Chills
    This report suggests a potential Oscal Respiratory Tract Congestion, Sinusitis, Hyperhidrosis, Tubulointerstitial Nephritis, Dehydration, Micturition Urgency, Renal Failure Acute, Chills side effect(s) that can have serious consequences. A 63-year-old male patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: NA and used Oscal (dosage: NA) starting Oct 27, 2010. Soon after starting Oscal the patient began experiencing various side effects, including:
    • Respiratory Tract Congestion
    • Sinusitis
    • Hyperhidrosis
    • Tubulointerstitial Nephritis
    • Dehydration
    • Micturition Urgency
    • Renal Failure Acute
    • Chills
    Drugs used concurrently:
    • Ibprofen
    • Pravastatin
    • Avelox
    • Aspirin
    • Avalide
    • Omeprazole (20mg Bid Po O47)
    • Metronidazole
    • Flovent
    The patient was hospitalized. Although Oscal demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as respiratory tract congestion, may still occur.

    Spinal Compression Fracture
    This Spinal Compression Fracture problem was reported by a physician from UNITED STATES. A 74-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Mar 01, 2011 this consumer started treatment with Oscal (dosage: 1000 Mg, Qd). The following drugs were being taken at the same time:
    • Vitamin D (400 Iu, Qd)
    • Spiriva (18 A?g, Qd)
    • Chantix (0.5 Mg, Bid)
    • Senokot
    • Denosumab (60 Mg, Q6mo)
    • Ferrous Sulfate Tab (27 Mg, Qd)
    • Hydralazine Hcl (10 Mg, Q6h)
    • Percocet (325 Mg, Prn)
    When commencing Oscal, the patient experienced the following unwanted symptoms/side effects:
    • Spinal Compression Fracture
    The patient was hospitalized and became disabled.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as spinal compression fracture, may become evident only after a product is in use by the general population.

    Haemorrhage, Ear Pruritus, Therapeutic Response Decreased, Dysphonia, Chills, Bronchospasm, Arthropathy, Pain, Hypertension
    This is a report of a female patient (weight: NA) from UNITED KINGDOM. The patient developed the following symptoms/conditions: NA and was treated with Oscal (dosage: Unk) starting Jan 01, 1986. Concurrently used drugs:
    • Osteonutri (Unk)
    • Hyzaar (hydrochlorothiazide/losartan) (Unk)
    • Alprazolam (Unk)
    Soon after that, the consumer experienced the following side effects:
    • Haemorrhage
    • Ear Pruritus
    • Therapeutic Response Decreased
    • Dysphonia
    • Chills
    • Bronchospasm
    • Arthropathy
    • Pain
    • Hypertension
    The patient was hospitalized. This opens a possibility that Oscal treatment could cause the above reactions, including haemorrhage, and some female subjects may be more susceptible.

    Rhinorrhoea, Nasopharyngitis, Fall, Flushing, Meniscus Lesion, Pruritus, Cough, Feeling Hot, Weight Increased
    A female patient (weight: NA) from UNITED STATES with the following symptoms/conditions: NA started Oscal treatment (dosage: NA) on Aug 01, 2010. Soon after starting Oscal treatment, the subject experienced various side effects, including:
    • Rhinorrhoea
    • Nasopharyngitis
    • Fall
    • Flushing
    • Meniscus Lesion
    • Pruritus
    • Cough
    • Feeling Hot
    • Weight Increased
    Concurrently used drugs:
    • Plavix
    • Aspirin
    • Diovan
    • Centrum
    • Niaspan (At Bedtime)
    • Lipitor
    This finding indicates that some female patients could be more vulnerable to Oscal.

    1 of 2 



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Oscal Side Effects

    Did You Have a Oscal Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Oscal for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Oscal Safety Alerts, Active Ingredients, Usage Information

    More About Oscal

    Side Effects reported to FDA: 37

    Oscal safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 6

    Latest Oscal clinical trials

    Oscal Reviews

    No reviews, be a first to report a side effect via side effect reporting form